Obesity management in Prader–Willi syndrome: current perspectives

References

• Cassidy SB Schwartz S Miller JL Driscoll DJ Prader-Willi syndrome Genet Med 2012 14 1 10 26 22237428
   PubMed Web of Science ®Google Scholar
• Lionti T Reid SM White SM Rowell MM A population-based profile of 160 Australians with Prader-Willi syndrome: trends in diagnosis, birth prevalence and birth characteristics Am J Med Genet A 2015 167 2 371 378
   Web of Science ®Google Scholar
• Butler MG Manzardo AM Forster JL Prader-Willi syndrome: clinical genetics and diagnostic aspects with treatment approaches Curr Pediatr Rev 2016 12 2 136 166 26592417
   PubMedGoogle Scholar
• Cho SY Ki CS Sohn YB The proportion of uniparental disomy is increased in Prader-Willi syndrome due to an advanced maternal child bearing age in Korea J Hum Genet 2013 58 3 150 154 23303386
   PubMed Web of Science ®Google Scholar
• Angulo MA Butler MG Cataletto ME Prader-Willi syndrome: a review of clinical, genetic and endocrine finding J Endocrinol Invest 2015 38 12 1249 1263 26062517
   PubMed Web of Science ®Google Scholar
• Heksch R Kamboj M Anglin K Obrynba K Review of Prader-Willi syndrome: the endocrine approach Transl Pediatr 2017 6 4 274 285 29184809
   PubMed Web of Science ®Google Scholar
• Tauber M Hauffa BP The clinical picture of PWS: childhood Hoybye C Prader-Willi Syndrome New York Nova Science Publishers 2013 45 56
   Google Scholar
• Gunay-Aygun M Schwartz S Heeger S O’Riordan MA Cassidy SB The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria Pediatrics 2001 108 5 E92 11694676
   PubMed Web of Science ®Google Scholar
• Goldstone AP Holland AJ Hauffa BP Hokken-Koelega AC Tauber M Speakers Contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS Recommendations for the diagnosis and management of Prader-Willi syndrome J Clin Endocrinol Metab 2008 93 11 4183 4197 18697869
   PubMed Web of Science ®Google Scholar
• Manzardo AM Loker J Heinemann J Loker C Butler MG Survival trends from the Prader–Willi Syndrome Association (USA) 40-year mortality survey Genet Med 2018 20 1 24 30 28682308
   PubMed Web of Science ®Google Scholar
• Diene G Mimoun E Feigerlova E Endocrine disorder in children with Prader-Willi syndrome – data from 142 children of the French database Horm Res Paediatr 2010 74 2 121 128 20395666
   PubMed Web of Science ®Google Scholar
• Grugni G Crinò A Bosio L Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology (ISPED) The Italian National Survey for Prader-Willi syndrome: an epidemiologic study Am J Med Genet A 2008 146 861 872
   Web of Science ®Google Scholar
• Sinnema M Maaskant MA van Schrojenstein Lantman-de Valk HM Physical health problems in adults with Prader-Willi syndrome Am J Med Genet A 2011 155 9 2112 2124
   Web of Science ®Google Scholar
• Miller JL Lynn CH Driscoll DC Nutritional phases in Prader-Willi syndrome Am J Med Genet A 2011 155 5 1040 1049
   Web of Science ®Google Scholar
• Bekx MT Carrel AL Shriver TC Li Z Allen DB Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi syndrome J Pediatr 2003 143 3 372 376 14517523
   PubMed Web of Science ®Google Scholar
• Goldstone AP Thomas EL Brynes AE Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution J Clin Endocrinol Metab 2001 86 9 4330 4338 11549670
   PubMed Web of Science ®Google Scholar
• Brambilla P Crinò A Bedogni G Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED) Metabolic syndrome in children with Prader-Willi syndrome: the effect of obesity Nutr Metab Cardiovasc Dis 2011 21 4 269 276 20089384
   PubMed Web of Science ®Google Scholar
• Talebizadeh Z Butler MG Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects Clin Genet 2004 67 3 230 239
   Web of Science ®Google Scholar
• Bedogni G Grugni G Tringali G Marazzi N Sartorio A Does segmental body composition differ in women with Prader–Willi syndrome compared to women with essential obesity? J Endocrinol Invest 2015 38 9 957 961 25840793
   PubMed Web of Science ®Google Scholar
• Swaab DF Prader-Willi syndrome and the hypothalamus Acta Paediatr Suppl 1997 86 423 50 54
   Google Scholar
• Xu M Zhang Y von Deneen KM Zhu H Gao J-H Brain structural alterations in obese children with and without Prader-Willi syndrome Hum Brain Mapp 2017 38 8 4228 4238 28543989
   PubMed Web of Science ®Google Scholar
• Polex-Wolf J Lam BYH Larder R Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome J Clin Invest 2018 128 3 960 969 29376887
   PubMed Web of Science ®Google Scholar
• Igarashi M Narayanaswami V Kimonis V Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome Pharmacol Res 2017 117 75 81 28007570
   PubMed Web of Science ®Google Scholar
• Dimitropoulos A Schultz RT Food-related neural circuitry in Prader-Willi syndrome: response to high- versus low-calorie foods J Autism Dev Disord 2008 38 9 1642 1653 18311513
   PubMed Web of Science ®Google Scholar
• Zhang Y Wang J Zhang G The neurobiological drive for overeating implicated in Prader–Willi syndrome Brain Res 2015 1620 72 80 25998539
   PubMed Web of Science ®Google Scholar
• Pujol J Blanco-Hinojo L Esteba-Castillo S Anomalous basal ganglia connectivity and obsessive-compulsive behaviour in patients with Prader-Willi syndrome J Psychiatry Neurosci 2016 41 4 261 271 26645739
   PubMed Web of Science ®Google Scholar
• Khan MJ Gerasimidis K Edwards CA Shaikh MG Mechanisms of obesity in Prader-Willi syndrome Pediatr Obes 2018 13 1 3 13 27863129
   PubMed Web of Science ®Google Scholar
• Goldstone AP Holland AJ Butler JV Whittington JE Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome Int J Obes (Lond) 2012 36 12 1564 1570 22270375
   PubMed Web of Science ®Google Scholar
• Proto C Romualdi D Cento RM Romano C Campagna G Lanzone A Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader-Willi and the Down syndromes Metabolism 2007 56 8 1076 1080 17618952
   PubMed Web of Science ®Google Scholar
• Irizarry KA Bain J Butler MG Metabolic profiling in Prader-Willi syndrome and non syndromic obesity: sex differences and the role of growth hormone Clin Endocrinol (Oxf) 2015 83 6 797 805 25736874
   PubMed Web of Science ®Google Scholar
• Bueno M Esteba-Castillo S Novell R Lack of postprandial peak in brain-derived neurotrophic factor in adults with Prader-Willi syndrome PLoS One 2016 11 9 e0163468 27685845
   PubMed Web of Science ®Google Scholar
• Höybye C Barkeling B Espelund U Petersson M Thorén M Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment Growth Horm IGF Res 2003 13 6 322 327 14624765
   PubMed Web of Science ®Google Scholar
• Haqq AM Muehlbauer MJ Newgard CB Grambow S Freemark M The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index J Clin Endocrinol Metab 2011 96 1 E225 E232 20962018
   PubMed Web of Science ®Google Scholar
• Purtell L Sze L Loughnan G In adults with Prader–Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels Neuropeptides 2011 45 4 301 307 21722955
   PubMed Web of Science ®Google Scholar
• Grugni G The endocrine system in PWS Hoybye C Prader-Willi Syndrome New York Nova Science Publishers 2013 107 119
   Google Scholar
• Bizzarri C Rigamonti AE Luce A Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children Eur J Endocrinol 2010 162 3 499 505 20019130
   PubMed Web of Science ®Google Scholar
• Rigamonti AE Bini S Piscitelli F Hedonic eating in Prader–Willi syndrome is associated with blunted PYY secretion Food Nutr Res 2017 61 1 1297553 28659728
   PubMed Web of Science ®Google Scholar
• Rigamonti AE Bini S Grugni G Unexpectedly increased anorexigenic postprandial responses of PYY and GLP-1 to fast ice cream consumption in adult patients with Prader-Willi syndrome Clin Endocrinol (Oxf) 2014 81 4 542 550 24372155
   PubMed Web of Science ®Google Scholar
• Butler MG Carlson MG Schmidt DE Feurer ID Thompson T Plasma cholecystokinin levels in Prader-Willi syndrome and obese subjects Am J Med Genet 2000 95 1 67 70 11074497
   PubMed Web of Science ®Google Scholar
• Paik KH Jin D-K Lee KH Peptide YY, cholecystokinin, insulin and ghrelin response to meal did not change, but mean serum levels of insulin is reduced in children with Prader-Willi syndrome J Korean Med Sci 2007 22 3 436 441 17596650
   PubMed Web of Science ®Google Scholar
• Zipf WB O’Dorisio TM Cataland S Dixon K Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome J Clin Endocrinol Metab 1983 57 5 1074 1080 6352724
   PubMed Web of Science ®Google Scholar
• Berntson GG Zipf WB O’Dorisio TM Hoffman JA Chance RE Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome Peptides 1993 14 3 497 503 8332550
   PubMed Web of Science ®Google Scholar
• Butler MG Bittel DC Plasma obestatin and ghrelin levels in subjects with Prader–Willi syndrome Am J Med Genet A 2007 143 5 415 421
   Web of Science ®Google Scholar
• Park WH Oh YJ Kim GY Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome J Clin Endocrinol Metab 2007 92 1 229 234 17047025
   PubMed Web of Science ®Google Scholar
• Dridi S Taouis M Adiponectin and energy homeostasis: consensus and controversy J Nutr Biochem 2009 20 11 831 839 19716279
   PubMed Web of Science ®Google Scholar
• Ma W Huang T Heianza Y Genetic variations of circulating adiponectin levels modulate changes in appetite in response to weight-loss diets J Clin Endocrinol Metab 2017 102 1 316 325 27841942
   PubMed Web of Science ®Google Scholar
• Goldstone AP Unmehopa UA Bloom SR Swaab DF Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects J Clin Endocrinol Metab 2002 87 2 927 937 11836343
   PubMed Web of Science ®Google Scholar
• Qi Y Purtell L Fu M Snord116 is critical in the regulation of food intake and body weight Sci Rep 2016 6 1 18614 26726071
   PubMed Web of Science ®Google Scholar
• Manzardo AM Johnson L Miller JL Driscoll DJ Butler MG Higher plasma orexin A levels in children with Prader-Willi syndrome compared with healthy unrelated sibling controls Am J Med Genet A 2016 170 9 2328 2333 27518917
   PubMed Web of Science ®Google Scholar
• Feigerlová E Diene G Conte-Auriol F Hyperghrelinemia precedes obesity in Prader–Willi syndrome J Clin Endocrinol Metab 2008 93 7 2800 2805 18460565
   PubMed Web of Science ®Google Scholar
• Irizarry KA Miller M Freemark M Haqq AM Prader Willi syndrome: genetics, metabolomics, hormonal function, and new approaches to therapy Adv Pediatr 2016 63 1 47 77 27426895
   PubMedGoogle Scholar
• Beauloye V Diene G Kuppens R High unacylated ghrelin levels support the concept of anorexia in infants with Prader-Willi syndrome Orphanet J Rare Dis 2016 11 1 56 27146407
   PubMed Web of Science ®Google Scholar
• Hedgeman E Ulrichsen SP Carter S Long-term health outcomes in patients with Prader-Willi syndrome: a nationwide cohort study in Denmark Int J Obes (Lond) 2017 41 10 1531 1538 28634363
   PubMed Web of Science ®Google Scholar
• Stevenson DA Heinemann J Angulo M Deaths due to choking in Prader-Willi syndrome Am J Med Genet A 2007 143 5 484 487
   Web of Science ®Google Scholar
• Stevenson DA Heinemann J Angulo M Gastric rupture and necrosis in Prader-Willi syndrome J Pediatr Gastroenterol Nutr 2007 45 2 272 274 17667731
   PubMed Web of Science ®Google Scholar
• Einfeld SL Kavanagh SJ Smith A Evans EJ Tonge BJ Taffe J Mortality in Prader-Willi syndrome Am J Ment Retard 2006 111 3 193 16597186
   PubMedGoogle Scholar
• Butler MG Manzardo AM Heinemann J Loker C Loker J Causes of death in Prader-Willi syndrome: Prader-Willi Syndrome Association (USA) 40-year mortality survey Genet Med 2017 19 6 635 642 27854358
   PubMed Web of Science ®Google Scholar
• Laurier V Lapeyrade A Copet P Medical, psychological and social features in a large cohort of adults with Prader-Willi syndrome: experience from a dedicated centre in France J Intellect Disabil Res 2015 59 5 411 421 24947991
   PubMed Web of Science ®Google Scholar
• Fintini D Grugni G Bocchini S Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED) Disorders of glucose metabolism in Prader-Willi syndrome: results of a multicenter Italian cohort study Nutr Metab Cardiovasc Dis 2016 26 9 842 847 27381990
   PubMed Web of Science ®Google Scholar
• Grugni G Crinò A Bedogni G Metabolic syndrome in adult patients with Prader-Willi syndrome Nutr Metab Cardiovasc Dis 2013 23 11 1134 1140 23220075
   PubMed Web of Science ®Google Scholar
• Miller JL Approach to the child with Prader-Willi syndrome J Clin Endocrinol Metab 2012 97 11 3837 3844 23129592
   PubMed Web of Science ®Google Scholar
• Cataletto M Angulo M Hertz G Whitman B Prader-Willi syndrome: a primer for clinicians Int J Pediatr Endocrinol 2011 2011 1 12 22008714
   PubMedGoogle Scholar
• McCandless SE Committee on Genetics Clinical report – health supervision for children with Prader-Willi syndrome Pediatrics 2011 127 1 195 204 21187304
   PubMed Web of Science ®Google Scholar
• Alsaif M Elliot SA Mackenzie ML Prado CM Field CJ Haqq AM Energy metabolism profile in individuals with Prader-Willi syndrome and implications for clinical management: a systematic review Adv Nutr 2017 8 6 905 915 29141973
   PubMed Web of Science ®Google Scholar
• Bonfig W Dokoupil K Schmidt H A special, strict, fat-reduced, and carbohydrate-modified diet leads to marked weight reduction even in overweight adolescents with Prader-Willi syndrome (PWS) Sci World J 2009 9 934 939
   Web of Science ®Google Scholar
• Barel G Balko K Viardot A Nutritional issues and their management in PWS Hoybye C Prader-Willi Syndrome New York Nova Science Publishers 2013 137 156
   Google Scholar
• Lima VP Emerich DR Mesquita ML Nutritional intervention with hypocaloric diet for weight control in children and adolescents with Prader-Willi Syndrome Eat Behav 2016 21 4 189 192 26970733
   PubMed Web of Science ®Google Scholar
• Miller JL Lynn CH Shuster J Driscoll DJ A reduced energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome J Hum Nutr Diet 2013 26 1 2 9 23078343
   PubMed Web of Science ®Google Scholar
• Butler MG Hanchett JM Thompson T Clinical findings and natural history of Prader-Willi syndrome Butler MG Lee PDK Whitman BY Management of Prader-Willi Syndrome New York, USA Springer 2006 3 48
   Google Scholar
• Gourash L Forster JL Regulation of weight in Prader-Willi syndrome: theoretical and practical considerations 2009 Available from: www.pittsburghpartnership.com
   Google Scholar
• Castner DM Tucker JM Wilson KS Rubin DA Patterns of habitual physical activity in youth with and without Prader-Willi syndrome Res Dev Disabil 2014 35 11 3081 3088 25129202
   PubMed Web of Science ®Google Scholar
• Reus L van Vlimmeren LA Staal JB Otten BJ Nijhuis-van der Sanden MW The effect of growth hormone treatment or physical training on motor performance in Prader-Willi syndrome: a systematic review Neurosci Biobehav Rev 2012 36 8 1817 1838 22652271
   PubMed Web of Science ®Google Scholar
• Griggs JL Sinnayah P Mathai ML Prader-Willi syndrome: from genetics to behaviour, with special focus on appetite treatments Neurosci Biobehav Rev 2015 59 155 172 26475993
   PubMed Web of Science ®Google Scholar
• Salehi P Leavitt A Beck AE Chen ML Roth CL Obesity management in Prader-Willi syndrome Pediatr Endocrinol Rev 2015 12 3 297 307 25962207
   PubMed Web of Science ®Google Scholar
• Sahebkar A Simental-Mendía LE Reiner Ž Effect of orlistat on plasma lipids and body weight: a systematic review and meta-analysis of 33 randomized controlled trials Pharmacol Res 2017 122 53 65 28559211
   PubMed Web of Science ®Google Scholar
• Butler MG Management of obesity in Prader-Willi syndrome Nat Clin Pract Endocrinol Metab 2006 2 11 592 593 17082801
   PubMedGoogle Scholar
• Miller JL Linville TD Dykens EM Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study J Pediatr Endocrinol Metab 2014 27 1–2 23 29 23893676
   PubMed Web of Science ®Google Scholar
• Hochberg I Hochberg Z Expanding the definition of hypothalamic obesity Obes Rev 2010 11 10 709 721 20233310
   PubMed Web of Science ®Google Scholar
• Padwal RS Majumdar SR Drug treatments for obesity: orlistat, sibutramine, and rimonabant Lancet 2007 369 9555 71 77 17208644
   PubMed Web of Science ®Google Scholar
• Kim GW Lin JE Blomain ES Waldman SA Antiobesity pharmacotherapy: new drugs and emerging targets Clin Pharmacol Ther 2014 95 1 53 66 24105257
   PubMed Web of Science ®Google Scholar
• Fidler MC Sanchez M Raether B A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial J Clin Endocrinol Metab 2011 96 10 3067 3077 21795446
   PubMed Web of Science ®Google Scholar
• Selikowitz M Sunman J Pendergast A Wright S Fenfluramine in Prader-Willi syndrome: a double blind, placebo controlled trial Arch Dis Child 1990 65 1 112 114 2405783
   PubMed Web of Science ®Google Scholar
• Garfield AS Davies JR Burke LK Increased alternate splicing of Htr2c in a mouse model for Prader-Willi syndrome leads disruption of 5HT2C receptor mediated appetite Mol Brain 2016 9 1 95 27931246
   PubMed Web of Science ®Google Scholar
• Motaghedi R Lipman EG Hogg JE Christos PJ Vogiatzi MG Angulo MA Psychiatric adverse effects of rimonabant in adults with Prader Willi syndrome Eur J Med Genet 2011 54 1 14 18 20965292
   PubMed Web of Science ®Google Scholar
• Billes SK Sinnayah P Cowley MA Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss Pharmacol Res 2014 84 1 11 24754973
   PubMed Web of Science ®Google Scholar
• Yanovski SZ Yanovski JA Naltrexone extended-release plus bupropion extended-release for treatment of obesity JAMA 2015 313 12 1213 1214 25803343
   PubMed Web of Science ®Google Scholar
• Benjamin E Buot-Smith T Naltrexone and fluoxetine in Prader-Willi syndrome J Am Acad Child Adolesc Psychiatry 1993 32 4 870 873 8340312
   PubMed Web of Science ®Google Scholar
• Zlotkin SH Fettes IM Stallings VA The effects of naltrexone, an oral beta-endorphin antagonist, in children with the Prader-Willi syndrome J Clin Endocrinol Metab 1986 63 5 1229 1232 2944913
   PubMed Web of Science ®Google Scholar
• Deal CL Tony M Hoybye C Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome J Clin Endocrinol Metab 2013 98 6 E1072 E1087 23543664
   PubMed Web of Science ®Google Scholar
• Carrel AL Myers SE Whitman BY Eickhoff J Allen DB Long-term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi syndrome J Clin Endocrinol Metab 2010 95 3 1131 1136 20061431
   PubMed Web of Science ®Google Scholar
• Höybye C Growth hormone treatment of Prader-Willi syndrome has long-term, positive effects on body composition Acta Paediatr 2015 104 4 422 427 25557351
   PubMed Web of Science ®Google Scholar
• Myers SE Whitman BY Carrel AL Moerchen V Bekx MT Allen DB Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits Am J Med Genet A 2007 143 5 443 448
   Web of Science ®Google Scholar
• Sipilä I Sintonen H Hietanen H Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome Acta Paediatr 2010 99 11 1712 1718 20545932
   PubMed Web of Science ®Google Scholar
• Bakker NE Kuppens RJ Siemensma EP Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects J Clin Endocrinol Metab 2013 98 10 4013 4022 24001750
   PubMed Web of Science ®Google Scholar
• Tan TM Vanderpump M Khoo B Patterson M Ghatei MA Goldstone AP Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome J Clin Endocrinol Metab 2004 89 8 4162 4165 15292365
   PubMed Web of Science ®Google Scholar
• de Waele K Ishkanian SL Bogarin R Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome Eur J Endocrinol 2008 159 4 381 388 18603572
   PubMed Web of Science ®Google Scholar
• Aman LCS Manning KE Whittington JE Holland AJ Mechanistic insights into the genetics of affective psychosis from Prader-Willi syndrome Lancet Psychiatry 2018 5 4 370 378 29352661
   PubMed Web of Science ®Google Scholar
• Shapira NA Lessig MC Lewis MH Goodman WK Driscoll DJ Effects of topiramate in adults with Prader-Willi syndrome Am J Ment Retard 2004 109 4 301 309 15176917
   PubMedGoogle Scholar
• Sze L Purtell L Jenkins A Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome J Clin Endocrinol Metab 2011 96 8 E1314 E1319 21632815
   PubMed Web of Science ®Google Scholar
• Seetho IW Jones G Thomson GA Fernando DJS Treating diabetes mellitus in Prader–Willi syndrome with exenatide Diabetes Res Clin Pract 2011 92 1 e1 e2 21227526
   PubMed Web of Science ®Google Scholar
• Arenz T Schwarzer A Pfluger T Koletzko S Schmidt H Delayed gastric emptying in patients with Prader Willi syndrome J Pediatr Endocrinol Metab 2010 23 9 867 871 21175084
   PubMed Web of Science ®Google Scholar
• Fintini D Grugni G Brufani C Bocchini S Cappa M Crino A Use of GLP-1 receptor agonists in Prader-Willi syndrome: report of six cases Diabetes Care 2014 37 4 e76 e77 24652737
   PubMed Web of Science ®Google Scholar
• Miller JL Strong TV Heinemann J Medical trials for hyperphagia and food-related behaviors in Prader-Willi syndrome Diseases 2015 3 2 78 85 28943610
   PubMedGoogle Scholar
• Kim DD Krishnarajah J Lillioja S Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial Diabetes Obes Metab 2015 17 6 566 572 25732625
   PubMed Web of Science ®Google Scholar
• Mccandless SE Yanovski JA Miller J Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: a randomized, double-blind, placebo-controlled trial Diabetes Obes Metab 2017 19 12 1751 1761 28556449
   PubMed Web of Science ®Google Scholar
• Burkey BF Hoglen NC Inskeep P Wyman M Hughes TE Vath JE Preclinical efficacy and safety of the novel antidiabetic, antiobesity MetAP2 inhibitor ZGN-1061 J Pharmacol Exp Ther 2018 365 2 301 313 29491038
   PubMed Web of Science ®Google Scholar
• Bischof JM van der Ploeg LH Colmers WF Wevrick R Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist Br J Pharmacol 2016 173 17 2614 2621 27339818
   PubMed Web of Science ®Google Scholar
• Bischof JM Wevrick R Chronic diazoxide treatment decreases fat mass and improves endurance capacity in an obese mouse model of Prader-Willi syndrome Mol Genet Metab 2018 123 4 511 517 29506955
   PubMed Web of Science ®Google Scholar
• Kimonis V Gold JA Surampalli A Wencel M Efficacy and safety of diazoxide choline controlled-release tablet in patients with Prader-Willi syndrome: an updated analysis Horm Res Paediatr 2017 88 suppl 1 211 P1 1611
   Google Scholar
• Einfeld SL Smith E Mcgregor IS A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome Am J Med Genet A 2014 164 9 2232 2239
   Web of Science ®Google Scholar
• Kuppens RJ Donze SH Hokken-Koelega AC Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial Clin Endocrinol (Oxf) 2016 85 6 979 987 27486141
   PubMed Web of Science ®Google Scholar
• Miller JL Tamura R Butler MG Oxytocin treatment in children with Prader-Willi syndrome: a double-blind, placebo-controlled, crossover study Am J Med Genet A 2017 173 5 1243 1250 28371242
   PubMed Web of Science ®Google Scholar
• Tauber M Boulanouar K Diene G The use of oxytocin to improve feeding and social skills in infants with Prader–Willi syndrome Pediatrics 2017 139 2 e20162976 28100688
   PubMed Web of Science ®Google Scholar
• Rice LJ Einfeld SL Hu N Carter CS A review of clinical trials of oxytocin in Prader-Willi syndrome Curr Opin Psychiatry 2018 31 2 123 127 29206687
   PubMed Web of Science ®Google Scholar
• Dykens EM Miller J Angulo M Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome JCI Insight 2018 3 12 98333 29925684
   PubMed Web of Science ®Google Scholar
• Allas S Caixas A Poitou C AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: a randomized placebo-controlled trial PLoS One 2018 13 1 e0190849 29320575
   PubMed Web of Science ®Google Scholar
• Griggs JL Su XQ Mathai ML Caralluma fimbriata supplementation improves the appetite behavior of children and adolescents with Prader-Willi syndrome Am J Med Sci 2015 7 11 509 516
   Google Scholar
• Ho AL Sussman ES Pendharkar AV Azagury DE Bohon C Halpern CH Deep brain stimulation for obesity: rationale and approach to trial design Neurosurg Focus 2015 38 6 E8
   Web of Science ®Google Scholar
• Bravo GL Poje AB Perissinotti I Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome Am J Med Genet B Neuropsychiatr Genet 2016 171B 2 266 275 26590516
   PubMed Web of Science ®Google Scholar
• Peterli R Wölnerhanssen BK Peters T Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial JAMA 2018 319 3 255 265 29340679
   PubMed Web of Science ®Google Scholar
• Iossa A De Peppo F Caccamo R Laparoscopic sleeve gastrectomy in adolescents with or without syndromic obesity: two years follow-up Eat Weight Disord 2018 23 4 479 486 28070780
   PubMed Web of Science ®Google Scholar
• Nobili V Vajro P Dezsofi A Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatol-ogy Committee Position Statement J Pediatr Gastroenterol Nutr 2015 60 4 550 561 25591123
   PubMed Web of Science ®Google Scholar
• Shoar S Mahmoudzadeh H Naderan M Long-term outcome of bariatric surgery in morbidly obese adolescents: a systematic review and meta-analysis of 950 patients with a minimum of 3 years followup Obes Surg 2017 27 12 3110 3117 28573535
   PubMed Web of Science ®Google Scholar
• Khidir N El-Matbouly MA Sargsyan D Five-year outcomes of laparoscopic sleeve gastrectomy: a comparison between adults and adolescents Obes Surg 2018 28 7 2040 2045 29430596
   PubMed Web of Science ®Google Scholar
• Alqahtani AR Elahmedi MO Al Qahtani AR Lee J Butler MG Laparoscopic gastrectomy in children and adolescents with Prader-Willi syndrome: a matched-control study Surg Obes Relat Dis 2016 12 1 100 110 26431633
   PubMed Web of Science ®Google Scholar
• Cazzo E Gestic MA Utrini MP Bariatric surgery in individuals with severe cognitive impairment: report of two cases Sao Paulo Med J 2018 136 1 84 88 28443951
   PubMed Web of Science ®Google Scholar
• Gibbons E Casey AF Brewster KZ Bariatric surgery and intellectual disability: furthering evidence-based practice Disabil Health J 2017 10 1 3 10 27720223
   PubMed Web of Science ®Google Scholar
• Michalik M Frask A Lech P Zdrojewski M Doboszynska A The usefulness of biliopancreatic diversion/Scopinaro operation in treatment of patients with Prader-Willi syndrome Wideochir Inne Tech Maloinwazyjne 2015 10 2 324 327 26240637
   PubMedGoogle Scholar
• Musella M Milone M Leongito M Maietta P Bianco P Pisapia A The mini-gastric bypass in the management of morbid obesity in Prader-Willi syndrome: a viable option? J Invest Surg 2014 27 2 102 105 24063639
   PubMed Web of Science ®Google Scholar
• Fong AK Wong SK Lam CC Ng EK Ghrelin level and weight loss after laparoscopic sleeve gastrectomy and gastric mini-bypass for Prader-Willi syndrome in Chinese Obes Surg 2012 22 11 1742 1745 22923339
   PubMed Web of Science ®Google Scholar
• Scheimann AO Butler MG Gourash L Cuffari C Klish W Critical analysis of bariatric procedures in Prader-Willi syndrome J Pediatr Gastroenterol Nutr 2008 46 1 80 83 18162838
   PubMed Web of Science ®Google Scholar
• Busetto L Dicker D Azran C Obesity Management Task Force of the European Association for the Study of Obesity released “practical recommendations for the post-bariatric surgery medical management” Obes Surg 2018 28 7 2117 2121 29725979
   PubMed Web of Science ®Google Scholar
• Moura D Oliveira J de Moura EG Effectiveness of intragastric balloon for obesity: a systematic review and meta-analysis based on randomized control trials Surg Obes Relat Dis 2016 12 2 420 429 26968503
   PubMed Web of Science ®Google Scholar
• De Peppo F Di Giorgio G Germani M BioEnterics intragastric balloon for treatment of morbid obesity in Prader-Willi syndrome Obes Surg 2008 18 11 1443 1449 18449615
   PubMed Web of Science ®Google Scholar
• Alqahtani AR Elahmedi M Alqahtani YA Bariatric surgery in monogenic and syndromic forms of obesity Semin Pediatr Surg 2014 23 1 37 42 24491367
   PubMed Web of Science ®Google Scholar